Tianjin Medical Journal ›› 2021, Vol. 49 ›› Issue (5): 550-555.doi: 10.11958/20202907

• Review • Previous Articles     Next Articles

Current progress in α-synuclein-based animal models of Parkinson's disease

DU Ke-chen1, 2, 3, ZOU Chun-lin1, 2, 3△   

  1. 1 Center for Translational Medicine, 2 Key Laboratory of Longevity and Aging-related Diseases, Ministry of Education, 
    3 School of Basic Medical Sciences, Guangxi Medical University, Nanning 530021, China
  • Received:2020-10-21 Revised:2021-02-09 Published:2021-05-15 Online:2021-05-25
  • Supported by:
    Funded by National Natural Science Foundation of China

Abstract:

Abstract: Parkinson's disease (PD) is the second most common neurodegenerative disease. A number of studies have shown that α-synuclein (α-syn) is closely related to the pathogenesis of Parkinson's disease. Domestic and foreign researchers have established PD animal models via the ectopic expression, overexpression or intracerebral injection of α-syn. In recent years, α-synuclein preformed fibrils (α-syn PFFs) have been used in the construction of animal models. α-syn PFFs play an important role in the study of the origin of PD and the transmission of neuronal degeneration. Compared with the toxin-induced models, these models can better reproduce the characteristics of pathological changes of PD patients. In this article, we mainly reviewed the research progress in α-synuclein-based animal models of PD.

Key words: Parkinson's disease, alpha-synuclein, models, animal, Lewy bodies, a-synuclein preformed fibrils